Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Carcinoma, Non-Small-Cell Lung × lenvatinib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 5 OTHER 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Carboplatin 28 Paclitaxel 22 Radiotherapy 20 Cisplatin 20 Docetaxel 15 Gemcitabine 12 Pemetrexed 11 Radiosurgery 9 Bevacizumab 8 Magnetic Resonance Spectroscopy 6 Etoposide 6 Gene Expression Profiling 5 Erlotinib Hydrochloride 5 Cetuximab 5 durvalumab 4 Vinorelbine 4 Specimen Handling 4 Ramucirumab 4 Polymerase Chain Reaction 4 cediranib 3 Watchful Waiting 3 Radiotherapy, Conformal 3 Psychiatric Rehabilitation 3 Neoadjuvant Therapy 3 Chemotherapy, Adjuvant 3 Amplified Fragment Length Polymorphism Analysis 3 selpercatinib 2 pembrolizumab 2 osimertinib 2 cemiplimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06068153 2024-11-20

AMBER

ETOP IBCSG Partners Foundation

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡